The problem of anaphylaxis and mastocytosis

Reimers A, Müller U: Fatal outcome of a Vespula sting in a patient with mastocytosis after specific immunotherapy with honey bee venom. Swiss Med Wkly 2005, 135(Suppl 144):S14.

Müller U, Morris T, Bischof M, et al.: Combined active and passive immunotherapy in honeybee-sting allergy. J Allergy Clin Immunol 1986, 78:115–122.

Johansson SGO, Bieber TH, Dahl R, et al.: Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004, 113:832–836.

Sampson HA, Munoz-Furlong A, Campbell RL, et al.: Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006, 117:391–397.

Pumphrey RSH: Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000, 30:1144–1150.

Yocum MW, Butterfield JH, Klein JS, et al.: Epidemiology of anaphylaxis in Olmstead County: a population based study. J Allergy Clin Immunol 1999, 104:452–456.

Helbling A, Thomas H, Müller U, Pichler WJ: Incidence of anaphylaxis with circulatory symptoms. A study over a 3-year period comprising 940 000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 2004, 34:285–290.

Bohlke K, Davis RL, DeStefano R, et al.: Epidemiology of anaphylaxis among children and adults enrolled in a health maintenance organization. J Allergy Clin Immunol 2004, 113:536–542.

Bresser H, Sandner CH, Rakoski J: Emergencies by insect stings in Munich 1992. Allergo J 2005, 7:373–376.

Peng MM, Jick H: A population based study of the incidence, cause and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004, 164:317–319.

Monneret-Vautrin DA, Morisset M, Flabee J, et al.: Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005, 60:443–451.

Valent P, Akin C, Escribano L, et al.: Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007, 37:435–453.

Castells MC: Mastocytosis: classification, diagnosis, and clinical presentation. Allergy Asthma Proc 2004, 25:33–36.

Brockow K: Markers of severity for systemic mastocytosis [in German]. Allergo J 2006, 15:273–279.

Greenhawt M, Akin C: Mastocytosis and allergy. Curr Opin Allergy Clin Immunol 2007, 74:387–392.

Tefferi A, Pardanani A: Systemic mastocytosis: current concepts and treatment advances. Curr Hematol Rep 2004, 3:197–202.

Valent P, Horny HP, Escribano L, et al.: Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001, 25:603–625.

Wolff K, Komar M, Petzelbauer P: Clinical and histopathological aspects of cutaneous mastocytosis. Leuk Res 2001, 25:519–528.

Hartmann K, Metcalfe DD: Pediatric mastocytosis. Hematol Oncol Clin North Am 2000, 14:625–640.

Akin C, Metcalfe DD: Systemic mastocytosis. Annu Rev Med 2004, 55:419–432.

Müller U, Helbling A, Hunziker T, et al.: Mastocytosis and atopy: a study in 33 patients with urticaria pigmentosa. Allergy 1990, 45:597–603.

González de Olano D, de la Hoz Caballer B, Núñez López R, et al.: Prevalence of allergy and anaphylactic symptoms in 219 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 2007, 37:1547–1555.

Brockow K, Jofer C, Behrendt H, Ring J: Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008, 63:226–232.

Müller U, Horat W, Wüthrich B, et al.: Anaphylaxis after Hymenoptera stings in 3 patients with urticaria pigmentosa. J Allergy Clin Immunol 1983, 72:685–689.

Price LA, Satko M: Bee venom allergy in a patient with urticaria pigmentosa. J Allergy Clin Immunol 1987, 79:407–409.

Kors JW, van Doormaal JJ, de Monchy JGR: Anaphylactoid shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med 1993, 233:255–258.

Fricker M, Helbling A, Schwartz LB, Müller U: Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in 10 patients. J Allergy Clin Immunol 1997, 100:11–15.

Oude Elberink JNG, de Monchy JGR, Kors JW, et al.: Fatal anaphylaxis after a yellow jacket sting in two patients with mastocytosis. J Allergy Clin Immunol 1997, 99:153–154.

Wagner N, Fritze D, Przybilla B, et al.: Fatal anaphylactic sting reaction in a patient with mastocytosis. Int Arch Allergy Immunol 2008, 146:162–163.

Pumphrey RSH, Roberts ISD: Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 2000, 53:273–276.

Dodd NJ, Bond MG: Fatal anaphylaxis in systemic mastocytosis. Clin Pathol 1979, 32:31–34.

Vaughan ST, Jones GN: Systemic mastocytosis presenting as profound cardiovascular collapse during anesthesia. Anaesthesia 1998, 53:804–807.

Florian S, Kraut MT, Simonitch-Klupp I, et al.: Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol 2005, 136:273–280.

Ruëff F, Placzek M, Przybilla B: Mastocytosis and Hymenoptera venom allergy. Curr Opin Allergy Clin Immunol 2006, 6:284–288.

Schwartz LB, Yunginger JW, Miller J, et al.: Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989, 83:1551–1555.

Schwartz LB, Bradford TR, Rouse C, et al.: Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol 1994, 14:190–204.

Ludolph-Hauser D, Ruëff F, Fries C, et al.: Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001, 357:361–362.

Haeberli G, Brönnimann M, Hunziker T, et al.: Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy. Clin Exp Allergy 2003, 33:1216–1220.

Kucharewicz I, Bodzenta-Lukaszyk A, Szymanski W, et al.: Basal serum tryptase level correlates with severity of Hymen optera sting and age. J Investig Allergol Clin Immunol 2007, 17:65–69.

Ruëff F, Bauer M, Placzek M, et al.: Treatment of mastocytosis. Allergologie 2006, 29:362–369.

Escribano L, Akin C, Castells M, Schwartz LB.: Current options in the treatment of mast cell mediator-related symptoms of mastocytosis. Inflamm Allergy Drug Targets 2006, 5:61–67.

Ring J, Brockow K, Duda D, et al.: Emergency treatment of anaphylactic reactions. Allergo J 2007, 16:420–434.

Wolff K: Treatment of cutaneous mastocytosis. Int Arch Allergy Immunol 2002, 127:156–159.

González de Olano D, Alvarez-Twose I, Esteban-López MI, et al.: Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol 2008, 121:519–526.

Bonadonna P, Zanotti R, Caruso B, et al.: Allergen specific immunotherapy is safe and effective in patients with mastocytosis and Hymenoptera allergy. J Allergy Clin Immunol 2008, 121:256–257.

Kontou-Fili K: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Allergy 2008, 63:376–378.

Reimers A, Hari Y, Müller U: Reduction of side effects from ultra-rush immunotherapy with honey bee venom by pre-treatment with fexofenadine: a double-blind placebo-controlled trial. Allergy 2000, 55:484–488.

Bonifazi F, Jutel M, Bilo BM, et al.: Prevention and treatment of Hymenoptera venom allergy. Allergy 2005, 60:1459–1470.